Jazz Pharmaceuticals plc buy Wells Fargo & Company
Start price
13.02.25
/
50%
€130.00
Target price
13.02.26
€163.54
Performance (%)
17.77%
Price
19:24
€153.10
Summary
This prediction is currently active. The prediction currently has a performance of 17.77%. This prediction currently runs until 13.02.26. The prediction end date can be changed by Wells_Fargo___Compan at any time. Wells_Fargo___Compan has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Jazz Pharmaceuticals plc | 31.603% | 31.603% |
| iShares Core DAX® | -4.104% | -3.234% |
| iShares Nasdaq 100 | -3.926% | -0.427% |
| iShares Nikkei 225® | -5.368% | -0.747% |
| iShares S&P 500 | -3.326% | 0.112% |
Comments by Wells_Fargo___Compan for this prediction
In the thread Jazz Pharmaceuticals plc diskutieren
Jazz Pharmaceuticals plc (NASDAQ: JAZZ) was upgraded by analysts at Wells Fargo & Company from an "equal weight" rating to an "overweight" rating. They now have a $170.00 price target on the stock, up previously from $130.00.
Ratings data for JAZZ provided by MarketBeat
Stopped prediction by Wells_Fargo___Compan for Jazz Pharmaceuticals plc
Jazz Pharmaceuticals plc
Start price
Target price
Perf. (%)
€155.95
18.11.25
18.11.25
€202.73
18.11.26
18.11.26
-0.83%
19:24
19:24
